{"entity":{"id":"cognitive-impairment-after-cancer-treatment","kind":"technology","name":"Thinking and memory after cancer treatment: what is measurable, and what helps","aka":[],"tldr":"Trouble with memory, concentration and word-finding after chemotherapy is real and measurable, and what a person reports and what a test shows often do not match. Cognitive rehabilitation is the approach with the best trial evidence, exercise helps on some measures and not others, and every drug tried so far has failed, including a large trial of donepezil.","summary":"What is reported. In a prospective study of 581 women with breast cancer and 364 age-matched controls, a clinically significant decline in self-reported cognitive function was reported by 45.2 per cent of patients against 10.4 per cent of controls from before to after chemotherapy, and 36.5 against 13.6 per cent at six months.\n\nWhat is measured. In the same cohort, objective testing showed patients declining from before chemotherapy to six months afterwards while controls did not, across multiple domains. A smaller study with full neuropsychological testing found cognitive dysfunction in 21 per cent before chemotherapy, decline in 65 per cent during it, and decline in 61 per cent at long-term evaluation, of whom 29 per cent had a new, delayed decline that had not been present earlier.\n\nThe mismatch between the two is the finding most worth telling a reader, because it is usually experienced as being disbelieved. A systematic review of 101 studies found that 31 showed no association between self-reported symptoms and neuropsychological results while 14 found one, often confined to limited domains. The authors describe \"consistently absent or weak association with neuropsychological test scores\". A normal test does not mean the difficulty is imagined; it means the test is measuring something else, usually in a quiet room with no competing demands.\n\nWhat helps. Cognitive rehabilitation has the best evidence. A web-based programme in 242 survivors significantly improved self-reported cognitive function at the end of the programme and at six months, although \"neuropsychological results were not significantly different between the groups\". A videoconference-delivered cognitive behavioural programme in 47 breast cancer survivors improved both perceived impairment and measured processing speed against supportive therapy. A network meta-analysis of 31 trials in 2,769 participants found small effects on subjective function and medium effects on total objective cognitive function, attention, executive function and learning and memory.\n\nExercise is mixed and should be described as mixed. A meta-analysis of 11 trials in 890 breast cancer survivors found significant effects on attention and working memory and on perceived cognitive ability, but the largest single trial, in 253 survivors, found no difference from a health and wellness comparison on either primary outcome, with improvement only in secondary measures of attention and memory.\n\nDrugs. Donepezil was tested properly: 276 breast cancer survivors across 87 practices, and at 24 weeks \"treatment groups did not differ\", with no significant difference at any timepoint on any domain. Methylphenidate given alongside adjuvant chemotherapy showed no difference on cognition or fatigue. The modafinil result often quoted for cognition came from a secondary analysis inside a fatigue trial using an open-label run-in and randomised withdrawal of responders, which is not evidence that it treats this. Memantine is a separate question belonging to brain radiotherapy rather than chemotherapy, and there it does have randomised support alongside hippocampal avoidance.\n\nWhat comes back, and when: partial, and mostly in the first year, with a minority developing a delayed decline instead. There is no drug that speeds it. Practical compensation, which is what cognitive rehabilitation teaches, is what the evidence supports, alongside treating the things that make it worse: fatigue, poor sleep, anxiety, pain, anaemia and an untreated thyroid.","status":"established","asOf":"2026-10-02","wikipedia":"https://en.wikipedia.org/wiki/Post-chemotherapy_cognitive_impairment","links":[{"label":"Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls (JCO 2017)","url":"https://doi.org/10.1200/JCO.2016.68.5826"},{"label":"Longitudinal trajectory and characterisation of cancer-related cognitive impairment in a nationwide cohort study (JCO 2018)","url":"https://doi.org/10.1200/JCO.2018.78.6624"},{"label":"Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer (Cancer 2010)","url":"https://doi.org/10.1002/cncr.25098"},{"label":"Systematic review of self-reported cognitive function in cancer patients following chemotherapy (J Cancer Surviv 2018)","url":"https://doi.org/10.1007/s11764-018-0692-x"},{"label":"Evaluation of a web-based cognitive rehabilitation programme in cancer survivors (JCO 2017)","url":"https://doi.org/10.1200/JCO.2016.67.8201"},{"label":"Videoconference-delivered cognitive behavioural therapy for survivors of breast cancer with cognitive dysfunction (Cancer 2016)","url":"https://doi.org/10.1002/cncr.29891"},{"label":"Effectiveness of cognitive rehabilitation: systematic review, pairwise and network meta-analysis (Int J Nurs Stud 2026)","url":"https://doi.org/10.1016/j.ijnurstu.2025.105298"},{"label":"Phase 3 randomised placebo-controlled trial of donepezil in breast cancer survivors after adjuvant chemotherapy (JCO 2024)","url":"https://doi.org/10.1200/JCO.23.01100"},{"label":"Effectiveness of an exercise intervention on cognition in breast cancer survivors: randomised controlled trial (JNCI 2026)","url":"https://doi.org/10.1093/jnci/djag295"},{"label":"International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function (Lancet Oncol 2011)","url":"https://doi.org/10.1016/S1470-2045(10)70294-1"}],"tags":["rejuvenation","survivorship","evidence:moderate"],"related":["idea-acc-cognitive-rehabilitation-after-chemotherapy","idea-moon-cognitive-toxicity-programme"],"cancers":["breast-hr-positive","tnbc","colorectal","testicular","dlbcl"],"sections":["rejuvenation","supportive-care","chemotherapy"],"technologies":["exercise-prescription-after-cancer","cbt-fatigue-distress","cbt-insomnia-cancer","mindfulness-based-interventions","cancer-related-fatigue-management","survivorship-care-plan"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["late-effects","quality-of-life"],"trials":[],"people":[],"bottlenecks":["b-survivorship","b-toxicity-qol"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"Chemotherapy, hormone withdrawal, inflammation, anaemia and disturbed sleep act together on frontal and hippocampal networks, which is why processing speed, working memory and executive function are the domains most affected. Standard neuropsychological tests measure peak performance in optimal conditions, while patients notice failures of divided attention in noisy, demanding settings, which is a plausible reason the two diverge.","strengths":["It is measurable, not imagined, and prospective controlled cohorts show it","Cognitive rehabilitation improves both reported and, in some trials, measured function","Treating fatigue, sleep, mood and anaemia improves cognition without a new drug"],"limitations":["Self-report and testing often disagree, which can leave patients disbelieved","Every drug tested has failed, including an adequately sized donepezil trial","The exercise evidence is positive in meta-analysis and negative in the largest single trial"]},"route":"/technologies/cognitive-impairment-after-cancer-treatment/","neighbours":{"idea":[{"id":"idea-moon-cognitive-toxicity-programme","kind":"idea","name":"Measure and treat chemo brain with objective digital cognitive testing","route":"/ideas/idea-moon-cognitive-toxicity-programme/"},{"id":"idea-acc-cognitive-rehabilitation-after-chemotherapy","kind":"idea","name":"Trials of structured cognitive rehabilitation for cancer-related cognitive impairment","route":"/ideas/idea-acc-cognitive-rehabilitation-after-chemotherapy/"}],"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"testicular","kind":"cancer","name":"Testicular germ cell tumours","route":"/cancers/testicular/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"section":[{"id":"chemotherapy","kind":"section","name":"Chemotherapy","route":"/fronts/chemotherapy/"},{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"cbt-fatigue-distress","kind":"technology","name":"Cognitive behavioural therapy for fatigue and distress","route":"/technologies/cbt-fatigue-distress/"},{"id":"cbt-insomnia-cancer","kind":"technology","name":"Cognitive behavioural therapy for insomnia (CBT-I)","route":"/technologies/cbt-insomnia-cancer/"},{"id":"rejuv-ayac-education-and-work","kind":"technology","name":"Education, work and the years that were interrupted","route":"/technologies/rejuv-ayac-education-and-work/"},{"id":"cancer-related-fatigue-management","kind":"technology","name":"Fatigue after cancer treatment: what actually works","route":"/technologies/cancer-related-fatigue-management/"},{"id":"rejuv-life-return-to-work","kind":"technology","name":"Going back to work after cancer: the rates, and the programmes that change them","route":"/technologies/rejuv-life-return-to-work/"},{"id":"rejuv-tx-icans-and-neurocognition","kind":"technology","name":"ICANS, and whether thinking recovers after CAR-T","route":"/technologies/rejuv-tx-icans-and-neurocognition/"},{"id":"rejuv-paed-neurocognitive","kind":"technology","name":"Memory, attention and learning after treatment of a childhood cancer","route":"/technologies/rejuv-paed-neurocognitive/"},{"id":"mindfulness-based-interventions","kind":"technology","name":"Mindfulness-based stress reduction and cognitive therapy","route":"/technologies/mindfulness-based-interventions/"},{"id":"rejuv-tx-quality-of-life","kind":"technology","name":"Quality of life after transplant and cell therapy","route":"/technologies/rejuv-tx-quality-of-life/"},{"id":"survivorship-care-plan","kind":"technology","name":"Survivorship care and late-effects surveillance","route":"/technologies/survivorship-care-plan/"},{"id":"exercise-prescription-after-cancer","kind":"technology","name":"The exercise prescription after cancer: the dose the guidelines state","route":"/technologies/exercise-prescription-after-cancer/"}],"term":[{"id":"late-effects","kind":"term","name":"Late effects and survivorship toxicity","route":"/terms/late-effects/"},{"id":"quality-of-life","kind":"term","name":"Quality of life","route":"/terms/quality-of-life/"}],"bottleneck":[{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"},{"id":"b-toxicity-qol","kind":"bottleneck","name":"Toxicity and quality of life are undervalued","route":"/bottlenecks/b-toxicity-qol/"}]}}